Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer

This multicenter phase II study first investigated the efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) when given every 3 weeks to patients with unresectable or recurrent gastric cancer who had received a prior round of fluoropyrimidine-containing chemotherapy. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Yasutsuna, Nishina, Tomohiro, Yasui, Hirofumi, Goto, Masahiro, Muro, Kei, Tsuji, Akihito, Koizumi, Wasaburo, Toh, Yasushi, Hara, Takuo, Miyata, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317911/
https://www.ncbi.nlm.nih.gov/pubmed/24716542
http://dx.doi.org/10.1111/cas.12419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317911/
https://www.ncbi.nlm.nih.gov/pubmed/24716542
http://dx.doi.org/10.1111/cas.12419

Ejemplares similares